Cover Image
市場調查報告書

Almac Discovery Ltd. - 製品管線製品分析

Almac Discovery Ltd. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 226297
出版日期 內容資訊 英文 32 Pages
訂單完成後即時交付
價格
Back to Top
Almac Discovery Ltd. - 製品管線製品分析 Almac Discovery Ltd. - Product Pipeline Review - 2015
出版日期: 2015年02月28日 內容資訊: 英文 32 Pages
簡介

Almac Discovery Ltd. 是針對症治療藥的創藥與開發製藥公司。在藥劑與小分子、肽治療、生物標記、開發診斷工具、特分類是前立腺癌、轉移管理、肽及蛋白質治療方面也很努力。

本報告針對Almac Discovery Ltd. 治療藥開發產品管線現況與各開發階段比較分析、藥劑標的、作用程制、用藥方式、分子種類分類治療藥評價、最新企業新聞與發表、後期階段與中止計畫相關情報。

Almac Discovery Ltd.基本情報

Almac Discovery Ltd.概要

  • 主要情報
  • 企業情報

Almac Discovery Ltd.:R&D概要

  • 主要治療範圍

Almac Discovery Ltd.:管線製品回顧

  • 開發階段分類管線製品製品
  • 單劑製品

Almac Discovery Ltd.:管線製品製品概況

  • 最終階段管線製品製品
    • 第III期製品/併用療法模式
  • 治療階段管線製品製品
    • 第I期製品/併用療法模式
  • 初期階段管線製品製品
    • 前臨床階段製品/併用療法模式
    • 創藥中製品/併用療法模式

Almac Discovery Ltd.:藥劑檔案

  • granisetron
  • ALM-201
  • AD-01
  • ALM-301
  • Small Molecule Targeting DNA for Oncology
  • Small Molecule to Inhibit WEE-1 for Cancer
  • Small Molecules to Modulate Deubiquitinating Enzymes for Cancers

Almac Discovery Ltd.:管線製品分析

  • 藥效分類
  • 標的分類
  • 用藥方式分類
  • 分子種類分類
  • 作用機制分類

Almac Discovery Ltd.:最近管線製品動向

Almac Discovery Ltd.:總公司與分公司所在地

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC06834CDB

Summary

Global Markets Direct's, 'Almac Discovery Ltd. - Product Pipeline Review - 2015', provides an overview of the Almac Discovery Ltd.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Almac Discovery Ltd.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Almac Discovery Ltd. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Almac Discovery Ltd.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Almac Discovery Ltd.'s pipeline products

Reasons to buy

  • Evaluate Almac Discovery Ltd.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Almac Discovery Ltd. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Almac Discovery Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Almac Discovery Ltd. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Almac Discovery Ltd.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Almac Discovery Ltd. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Almac Discovery Ltd. Snapshot
    • Almac Discovery Ltd. Overview
    • Key Information
    • Key Facts
  • Almac Discovery Ltd. - Research and Development Overview
    • Key Therapeutic Areas
  • Almac Discovery Ltd. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Almac Discovery Ltd. - Pipeline Products Glance
    • Almac Discovery Ltd. - Clinical Stage Pipeline Products
      • Phase I Products/Combination Treatment Modalities
    • Almac Discovery Ltd. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
    • Almac Discovery Ltd. - Unknown Stage Pipeline Products
      • Unknown Products/Combination Treatment Modalities
  • Almac Discovery Ltd. - Drug Profiles
    • ALM-201
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • AD-01
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ADC-0008830
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ALM-301
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecules to Inhibit Akt1/2 for Cancer
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule to Inhibit WEE-1 for Cancer
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecules to Modulate Deubiquitinating Enzymes for Cancers
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecules to Target DNA for Oncology
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecules for Cancer
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Almac Discovery Ltd. - Pipeline Analysis
    • Almac Discovery Ltd. - Pipeline Products by Target
    • Almac Discovery Ltd. - Pipeline Products by Route of Administration
    • Almac Discovery Ltd. - Pipeline Products by Molecule Type
    • Almac Discovery Ltd. - Pipeline Products by Mechanism of Action
  • Almac Discovery Ltd. - Recent Pipeline Updates
  • Almac Discovery Ltd. - Dormant Projects
  • Almac Discovery Ltd. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Almac Discovery Ltd., Key Information
  • Almac Discovery Ltd., Key Facts
  • Almac Discovery Ltd. - Pipeline by Indication, 2015
  • Almac Discovery Ltd. - Pipeline by Stage of Development, 2015
  • Almac Discovery Ltd. - Monotherapy Products in Pipeline, 2015
  • Almac Discovery Ltd. - Phase I, 2015
  • Almac Discovery Ltd. - Preclinical, 2015
  • Almac Discovery Ltd. - Discovery, 2015
  • Almac Discovery Ltd. - Unknown, 2015
  • Almac Discovery Ltd. - Pipeline by Target, 2015
  • Almac Discovery Ltd. - Pipeline by Route of Administration, 2015
  • Almac Discovery Ltd. - Pipeline by Molecule Type, 2015
  • Almac Discovery Ltd. - Pipeline Products by Mechanism of Action, 2015
  • Almac Discovery Ltd. - Recent Pipeline Updates, 2015
  • Almac Discovery Ltd. - Dormant Developmental Projects,2015

List of Figures

  • Almac Discovery Ltd. - Pipeline by Top 10 Indication, 2015
  • Almac Discovery Ltd. - Pipeline by Stage of Development, 2015
  • Almac Discovery Ltd. - Monotherapy Products in Pipeline, 2015
  • Almac Discovery Ltd. - Pipeline by Top 10 Target, 2015
  • Almac Discovery Ltd. - Pipeline by Top 10 Route of Administration, 2015
  • Almac Discovery Ltd. - Pipeline by Top 10 Molecule Type, 2015
  • Almac Discovery Ltd. - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top